Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Major EU grant to develop cancer-fighting cells

08.11.2005


A pre-clinical research project coordinated by The University of Manchester, which will advance understanding of how cancer cells evade the immune system, has been awarded nearly €12m by the EU. The European Union Framework Programme (FP6) will enable doctors to improve ‘T-cell mediated immunotherapy’, which has the potential to fight a broad range of cancers.



The five year ‘ATTACK’ Project (Adoptive engineered T-cell Targeting to Activate Cancer Killing), involves an international consortium of 16 partners, who will collaborate on the process of engineering T-cells.

T-cells are part of the body’s immune defense machinery which naturally protects against infections and some cancers and can be used to treat some malignant disease, but many cancers avoid destruction by the immune system. The project team hopes that state of the art technologies can be used to modify the T-cells, to hunt down and destroy cancer tumours.


Robert Hawkins, Cancer Research UK Professor of Medical Oncology at The University of Manchester, said: “Unlike radiotherapy and chemotherapy, which destroy both cancerous and healthy cells, Engineered T-cell Therapy has the potential to selectively destroy cancers within a patient’s body using its own infection-fighting mechanisms. This project focuses on optimising that system in the laboratory.

“The ultimate aim is to develop a process whereby T-cells are taken from the blood of a patient, genetically modified to enable them to target tumours, multiplied in the laboratory and injected in large numbers back into the patient.

The approach stems from original research by Professor Zelig Eshhar in Israel, and the partners include experts in immunology and tumour biology as well as those who have developed key aspects of engineered T-cells. Professor Hawkins continued:

“Already vaccines can prevent certain cancers, and the aim of this project is to develop effective methods to target others. By bringing together many of the leading immunotherapy groups in Europe we will be able to combine basic scientific expertise, new technologies and experience in pre-clinical testing, and our co-ordinated efforts should facilitate enormous progress.

“We expect the project to lead to many more trials in the future and are hopeful it could lead to real improvements in treatment.”

Professor Nic Jones, head of the Paterson Institute for Cancer Research where the project will be based, said: “Developments in cancer treatment are likely to require major team efforts, and we are delighted that the consortium has been awarded this major international grant. Cancer immunotherapy is a very exciting area and one that we are seeking to expand further in Manchester; we are already building a new Gene Therapy Centre funded by the Christie Appeal and are hoping to recruit other leading researchers in this field.”

Caroline Shaw, Chief Executive of the Christie Hospital said; “This is fantastic news for Professor Hawkins and his research team, for Manchester and most importantly for patients. Cancer research in Manchester is going from strength to strength and it’s the patients who will ultimately benefit.”

Jo Nightingale | alfa
Further information:
http://www.manchester.ac.uk/aboutus/news/pressreleases/majoreugranttodevelopcancer-fightingcells7november2005/

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>